Yang Jingyi, Yuan Minlan, Zhang Wei
Mental Health Center and Psychiatric Laboratory, the State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China.
Front Psychiatry. 2024 Sep 24;15:1460631. doi: 10.3389/fpsyt.2024.1460631. eCollection 2024.
Mood disorders, including major depressive disorder and bipolar disorder, have a profound impact on more than 300 million people worldwide. It has been demonstrated mood disorders were closely associated with deviations in biogenic amine metabolites, which are involved in numerous critical physiological processes. The peripheral and central alteration of biogenic amine metabolites in patients may be one of the potential pathogeneses of mood disorders. This review provides a concise overview of the latest research on biogenic amine metabolites in mood disorders, such as histamine, kynurenine, and creatine. Further studies need larger sample sizes and multi-center collaboration. Investigating the changes of biogenic amine metabolites in mood disorders can provide biological foundation for diagnosis, offer guidance for more potent treatments, and aid in elucidating the biological mechanisms underlying mood disorders.
情绪障碍,包括重度抑郁症和双相情感障碍,对全球超过3亿人产生了深远影响。已有研究表明,情绪障碍与生物胺代谢产物的偏差密切相关,这些代谢产物参与了众多关键的生理过程。患者体内生物胺代谢产物的外周和中枢改变可能是情绪障碍的潜在发病机制之一。本综述简要概述了情绪障碍中生物胺代谢产物的最新研究,如组胺、犬尿氨酸和肌酸。进一步的研究需要更大的样本量和多中心合作。研究情绪障碍中生物胺代谢产物的变化可为诊断提供生物学基础,为更有效的治疗提供指导,并有助于阐明情绪障碍的生物学机制。